Cargando…
H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Acetylation and deacetylation are posttranslational modifications (PTMs) which affect the regulation of chromatin structure and its remodeling. Acetylation of histone 3 at lysine placed on position 18 (H3K18Ac) plays an important role in driving progression of many types of cancer, including breast,...
Autores principales: | Hałasa, Marta, Wawruszak, Anna, Przybyszewska, Alicja, Jaruga, Anna, Guz, Małgorzata, Kałafut, Joanna, Stepulak, Andrzej, Cybulski, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562857/ https://www.ncbi.nlm.nih.gov/pubmed/31121824 http://dx.doi.org/10.3390/cells8050485 |
Ejemplares similares
-
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2019) -
Deacetylation of Transcription Factors in Carcinogenesis
por: Halasa, Marta, et al.
Publicado: (2021) -
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis
por: Wawruszak, Anna, et al.
Publicado: (2019) -
Valproic Acid and Breast Cancer: State of the Art in 2021
por: Wawruszak, Anna, et al.
Publicado: (2021) -
Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
por: Okon, Estera, et al.
Publicado: (2020)